(Q40017412)

English

Does pegylated interferon alpha-2b confer additional benefit in the adjuvant treatment of high-risk melanoma?

scientific article published on 17 December 2008

In more languages
default for all languages
No label defined

No description defined

Statements

Does pegylated interferon alpha-2b confer additional benefit in the adjuvant treatment of high-risk melanoma? (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit